Works about TOPOTECAN


Results: 293
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study.

    Published in:
    Cancer Research & Treatment, 2018, v. 50, n. 1, p. 148, doi. 10.4143/crt.2016.511
    By:
    • Amoroso, Loredana;
    • Erminio, Giovanni;
    • Makin, Guy;
    • Pearson, Andrew D. J.;
    • Brock, Penelope;
    • Valteau-Couanet, Dominique;
    • Castel, Victoria;
    • Pasquet, Marlène;
    • Laureys, Genevieve;
    • Thomas, Caroline;
    • Luksch, Roberto;
    • Ladenstein, Ruth;
    • Haupt, Riccardo;
    • Garaventa, Alberto
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer.

    Published in:
    2021
    By:
    • Yan, Shunfei;
    • Xuan, Jiachen;
    • Brajanovski, Natalie;
    • Tancock, Madeleine R. C.;
    • Madhamshettiwar, Piyush B.;
    • Simpson, Kaylene J.;
    • Ellis, Sarah;
    • Kang, Jian;
    • Cullinane, Carleen;
    • Sheppard, Karen E.;
    • Hannan, Katherine M.;
    • Hannan, Ross D.;
    • Sanij, Elaine;
    • Pearson, Richard B.;
    • Chan, Keefe T.
    Publication type:
    journal article
    20
    21
    22
    23

    Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life.

    Published in:
    2016
    By:
    • Brotto, Lori;
    • Brundage, Michael;
    • Hoskins, Paul;
    • Vergote, Ignace;
    • Cervantes, Andres;
    • Casado, Herraez;
    • Poveda, A.;
    • Eisenhauer, Elizabeth;
    • Tu, Dongsheng;
    • Casado, Herraez A;
    • Gynecologic Cancer Intergroup Study of the NCIC Clinical Trials Group (NCIC CTG), the European Organization for Research and Treatment of Cancer—Gynecologic Cancer Group (EORTC-GCG) and the Grupo de Investigación de Cáncer de Ovario;
    • Gynecologic Cancer Intergroup Study of NCIC Clinical Trials Group (NCIC CTG);
    • European Organization for Research and Treatment of Cancer - Gynecologic Cancer Group (EORTC-GCG);
    • Grupo de Investigación de Cáncer de Ovario (GEICO)
    Publication type:
    journal article
    24

    Second Line Treatment Choice in Extensive Small Lung Cancer.

    Published in:
    Eurasian Journal of Medical Investigation, 2022, v. 6, n. 4, p. 456, doi. 10.14744/ejmi.2022.72208
    By:
    • Ay, Seval;
    • Ozyukseler, Deniz Tataroglu;
    • Dulgar, Ozgecan;
    • Atci, Muhammed Mustafa;
    • Arikan, Rukiye;
    • Akbiyik, Ayten Guner;
    • Gumus, Mahmut
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Comeback for the camptothecins?

    Published in:
    Leukemia & Lymphoma, 2009, v. 50, n. 12, p. 1914, doi. 10.3109/10428190903291088
    By:
    • Kirschbaum, Mark
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Surface contamination of cytotoxic medicine in preparation and patient care areas in Australian hospitals: a retrospective cross‐sectional study.

    Published in:
    Journal of Pharmacy Practice & Research, 2024, v. 54, n. 4, p. 306, doi. 10.1002/jppr.1925
    By:
    • Woodward, Vincent;
    • Panjarjian, Meghrie;
    • Devi, Devika;
    • Hanrahan, Jane;
    • Soriano, Michael;
    • Roper, Matt;
    • Musa, Hala;
    • Davies, Stephanie;
    • Samios, Peter;
    • Teh, Michael;
    • Barclay, Peter;
    • Naughtin, Clare;
    • Vaillancourt, Régis;
    • Nikolaidis, Carl;
    • Pelland, Bryan;
    • Penm, Jonathan
    Publication type:
    Article
    48

    US SAFETY BRIEFS.

    Published in:
    Journal of Pharmacy Practice & Research, 2013, v. 43, n. 4, p. 300
    Publication type:
    Article
    49
    50